Are People Living With Dementia Receiving High Intensity Statin Therapy After Stroke? A Population‐Based Cohort Study
Guidelines recommend all people with reasonable life expectancy receive a high-intensity statin after stroke to reduce the risk of recurrent stroke and other adverse cardiovascular events. More research is needed to understand why people living with dementia might not receive guideline recommended care, and how statin use and statin intensity impact the health outcomes of people living with dementia and stroke.
Authors
- Leonie Picton (ORCID: https://orcid.org/0000-0002-9472-8531)
- Jenni Ilomäki (ORCID: https://orcid.org/0000-0002-0348-9441)
- Johnson George (ORCID: https://orcid.org/0000-0002-0326-0495)
- J. Simon Bell (ORCID: https://orcid.org/0000-0002-6115-2767)
Institutions
- Monash Health (AU)
- Monash University (AU)
Publication Details
- Journal
- Health Science Reports
- Published
- 2024-11-01
- DOI
- https://doi.org/10.1002/hsr2.70165
- Citations
- 1
- Primary Topic
- Lipoproteins and Cardiovascular Health
- Type
- article
- Field-Weighted Citation Impact
- 0.57
Funders
- Amgen
- Pfizer
- AstraZeneca
- Australian Government
- National Breast Cancer Foundation
- Dementia Australia
- Medical Research Council
- National Health and Medical Research Council